Okay. Believe what you will about being delinquent on taxes (2014 1Q & 2Q). We can see by all the lenders willing to risk their money in this company without the very lucrative and nearly guaranteed returns of toxic financing (exactly zero lenders) or secured with accounts receivable how failing to pay $1.1 million in payroll taxes means nothing. BTW, the 2013 delinquent taxes are not paid in full- far from it. That's called delinquent. Thus there are liens to secure the installment agreement unless you want to seriously advance the argument that the IRS places liens on businesses that are current on their taxes. lol
As for the assets (might want to recheck that cash claim)...how do they compare to the total debt? yeah...
EBITDA is positive. Wohoo. Where is so much as one penny of net income?
"Low risk high profit business"...ROTFLMAO! There is something called the law of supply and demand that is absent here. But let's assume there are such accounts. If Schadel knew what the hell he was doing he would have had the supposedly more lucrative accounts set up to replace the "culled" (probably just "lost") business so that the impact would have been barely noticed if at all. The revenue performance ever since that so-called plan was first announced a few months ago has been telling in that regard- no such accounts. I expect the 10Q will be equally telling.
Traditional lending "never" seen for an OTC company? Really? Boy that sounds factual. Look at CCNI to see how it's supposed to be done from the first 10K to now. THAT was a struggling company trying to do things the right way and succeeded. Not this Schadel BS of endless toxic financing.
As for the AS...look again at the filings. The original AS was 75 million- not 100 million. It doubled without so much as a peep from Schadel.
What you said here was interesting, though:
"Adversity creates opportunity. A cheap stock is a positive in my book!"
...hmmmm.
News 
Market Data 
Discover 
AI
